Dare Bioscience Inc (DARE)
0.3112
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3112
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Cash from Operations (TTM): -38.86M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -38.86M |
September 30, 2023 | -36.57M |
June 30, 2023 | -20.00M |
March 31, 2023 | -21.86M |
December 31, 2022 | -18.09M |
September 30, 2022 | -22.11M |
June 30, 2022 | -29.39M |
March 31, 2022 | -32.73M |
December 31, 2021 | -28.76M |
September 30, 2021 | -28.04M |
June 30, 2021 | -34.72M |
March 31, 2021 | -27.01M |
December 31, 2020 | -25.23M |
September 30, 2020 | -19.85M |
June 30, 2020 | -17.67M |
March 31, 2020 | -16.60M |
December 31, 2019 | -13.32M |
September 30, 2019 | -12.22M |
June 30, 2019 | -11.79M |
March 31, 2019 | -11.46M |
December 31, 2018 | -10.27M |
Date | Value |
---|---|
September 30, 2018 | -8.519M |
June 30, 2018 | -7.188M |
March 31, 2018 | -4.608M |
December 31, 2017 | -2.540M |
September 30, 2017 | -1.746M |
June 30, 2017 | 23.97M |
March 31, 2017 | 12.84M |
December 31, 2016 | -0.3723M |
September 30, 2016 | -8.415M |
June 30, 2016 | -40.68M |
March 31, 2016 | -37.23M |
December 31, 2015 | -31.92M |
September 30, 2015 | -29.31M |
June 30, 2015 | -26.90M |
March 31, 2015 | -23.34M |
December 31, 2014 | -19.06M |
September 30, 2014 | -16.72M |
June 30, 2014 | -14.39M |
March 31, 2014 | -15.68M |
December 31, 2013 | -16.61M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-38.86M
Minimum
Dec 2023
-11.79M
Maximum
Jun 2019
-23.94M
Average
-22.11M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Altimmune Inc | -75.81M |
Verastem Inc | -86.46M |
Oragenics Inc | -7.291M |
Actinium Pharmaceuticals Inc | -39.63M |
Orgenesis Inc | -14.84M |